# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001367644-22-000072
Filing Date
2022-05-16
Accepted
2022-05-16 06:49:30
Documents
17
Period of Report
2022-05-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | ebs-20220516.htm iXBRL | 8-K | 34369
2 | EX-99 | a051622-emergenttoacquir.htm | EX-99 | 10834
7 | GRAPHIC | a051622-emergenttoacquir001.jpg | GRAPHIC | 205415
8 | GRAPHIC | a051622-emergenttoacquir002.jpg | GRAPHIC | 254676
9 | GRAPHIC | a051622-emergenttoacquir003.jpg | GRAPHIC | 178593
| Complete submission text file | 0001367644-22-000072.txt |  | 1083204

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | ebs-20220516.xsd | EX-101.SCH | 2218
4 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | ebs-20220516_def.xml | EX-101.DEF | 2933
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | ebs-20220516_lab.xml | EX-101.LAB | 27198
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | ebs-20220516_pre.xml | EX-101.PRE | 14705
11 | EXTRACTED XBRL INSTANCE DOCUMENT | ebs-20220516_htm.xml | XML | 11009

Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 22925348
SIC: 2834 Pharmaceutical Preparations